Biotech Tests Important Resistance

03/14/2013 7:00 am EST

Focus: ETFs

While a top in a bull rally cannot be forecasted ahead of time, there are levels that traders need to be watching, writes Frank Kollar of

One level is now being tested by Market Vectors Biotech (BBH).

BBH spent a month at the $58.53 resistance level before blasting through in the end of February.

BBH is now at what we see as critical resistance, $61.00 to $62.00 a share.

A decisive close and then continued upside would confirm the current rally and forecast even higher highs ahead.

Chart Courtesy of
Click to Enlarge

But if BBH begins a pullback, this is where we expect to see it start. A reversal day or inability to push well above $62.00 a share in the next week would be a bearish sign for this ETF and the entire sector.

That said, we are and have been long BBH and continue to hold a bullish position. If we make a decisive close above current levels, we could see considerably higher highs ahead.

As of this writing, BBH is at $63.38, just fractionally above resistance.

By Frank Kollar, Editor,

  By clicking submit, you agree to our privacy policy & terms of service.

Related Articles on ETFs